Related Experiment Videos
Glucose modulation of alterations in serum iodothyronine concentrations induced by fasting
Metabolism: Clinical and Experimental
|April 1, 1979
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Novel biomarker SYT12 may contribute to predicting papillary thyroid cancer outcomes.
Future science OA·2017
A 2013 European survey of clinical practice patterns in the management of Graves' disease.
Clinical endocrinology·2015
Ghrelin receptor-knockout mice display alterations in circadian rhythms of activity and feeding under constant lighting conditions.
The European journal of neuroscience·2013
Addition of chlorine during water purification reduces iodine content of drinking water and contributes to iodine deficiency.
Journal of endocrinological investigation·2011
Improved endothelial function and lipid profile compensate for impaired hemostatic and inflammatory status in iatrogenic chronic subclinical hyperthyroidism of thyroid cancer patients on L-t4 therapy.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2009
The relative frequency in which empiric dosages of radioiodine would potentially overtreat or undertreat patients who have metastatic well-differentiated thyroid cancer.
Thyroid : official journal of the American Thyroid Association·2006
Pan-PPAR agonists: emerging therapeutic strategies for metabolic dysfunction-associated steatotic liver disease.
Metabolism: clinical and experimental·2026
Oxidative balance-related metabolite signature and incident cardiovascular disease and type 2 diabetes within the PREDIMED trial.
Metabolism: clinical and experimental·2026
Brca1 heterozygosity leads to hepatic steatosis in male and female mice despite sexually dimorphic effects on systemic metabolism.
Metabolism: clinical and experimental·2026
ASB3 limits adipocyte thermogenesis and energy expenditure through p62 ubiquitination.
Metabolism: clinical and experimental·2026
Hepatic MED1 disruption ameliorates obesity-related fatty liver by attenuating SREBP1-driven lipogenesis.
Metabolism: clinical and experimental·2026